The role of Yogic breathing techniques in progression and recovery from COVID-19

INTERVENTION: Intervention1: Yogic breathing: Yoga:SHORT DURATION BREATHING TECHNIQUE(SDBT) Time Interval : 3‐5 minutes Preparation: eyes closed, sit with cross legs Process: Powerful inhalation/ exhalation (Bhastrika pranayama) 21 times with constrictions from the throat and no abdominal jerks. It is followed by sitting relaxed with fullness of breath for 30 sec ‐ 1 min (Mouth closed, Eyes closed) Yoga: LONGER DURATION BREATHING TECHNIQUE(LDBT) Time interval: 12‐18 minutes Preparation: Crossed leg posture with straight spine, hands‐on thighs with palms facing upwards, face slightly upwards, mild focus between the eyebrows Process has 3 Stages (Yogic Breathing with A kaara chanting) Stage 1: Inhale / Exhale while inhaling mentally saying, I am not the body and while exhaling mentally saying, I am not even the mind., Stage 2: Utter â??aaâ?? 7 times, producing the sound from the navel region with mouth wide open. Not very loud but enough to feel the vibrations produced by the sound Stage 3: Sit silent for 5‐6 minutes with face slightly upwards with mild focus between the eyebrows. Control Intervention1: Yogic breathing: SDBT: 15 day intervention on COVID‐positive Control Intervention2: No intervention: COVID‐positive with usual care. Control Intervention3: Yogic breathing : SDBT and LDBT: 15 day intervention on COVID recovered and health care worker. Control Intervention4: No intervention: COVID recovered and health care worker with no intervention will act as control. CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: Anxiety, stress, post traumatic stress, triguna, tridosha, Mental wellbeing, wellness and resilience ; Timepoint: baseline, after 15 days SECONDARY OUTCOME: CBC, LFT, KFT, CRP, Procalcitonin, blood clotting timeTimepoint: All parameters will be assessed at baseline, after 7 days and after 15 days. IgG, IgMTimepoint: 28th day from enrollment INCLUSION CRITERIA: The Quarantined COVID‐19 suspects, COVID‐19 convalescent and COVID‐19 positive patients will be enrolled in the study based on their quarantined venue, recovery or the admission to the hospital, as the case may be, after the initial screening as per the Institutes guidelines. Patients between the age group of 15 â?? 70 years will be considered for this study.